< Back to the Newsroom

New strategic partnership to improve access to medical-grade thermoplastic polyurethanes

We are thrilled to announce our new partnership with Biomerics, a leading provider of medical polymers. This collaboration will enhance our ability to distribute Biomerics’ specialty medical grade thermoplastic polyurethanes throughout Europe.

 

A complete range of medical materials

Formulance will handle the distribution of Biomerics’ full range of iconic products such as Quadrathane™, Quadraflex™ and Quadraplast™. These materials are essential in many medical applications, including:

  • Vascular access catheters
  • Introductions
  • Drainage catheters
  • Interventional radiology devices
  • Fluid management products
  • Coatings and balloons
  • Wound care

 

Standards-compliant biomaterials

The Quadra family of biomaterials features a wide range of hardnesses, colours and radiopacifiers, all designed to meet strict quality and biocompatibility standards. They comply with ISO-10993 and USP Class VI standards, guaranteeing their safety and efficacy for patients.

Biomerics and Formulance will also offer a standard stocking programme for the most common materials, as well as a complete compounding and packaging service, ensuring a seamless supply chain for manufacturers.

 

Why is this partnership important?

As Samuel Ducros, our Managing Director, states, “The addition of Biomerics medical urethanes expands Formulance’s portfolio of elastomers for medical device manufacturers. Biomerics specialty offerings hold a distinctive position in the healthcare industry and are an excellent complement to our healthcare solutions strategy.”

This alliance aims to improve access to Biomerics’ technologies and materials, responding to the growing demand for innovation in the healthcare sector.

Travis Sessions, CEO of Biomerics, explains that “We chose Formulance for its commitment to the medical device market, its reliability in distribution and its excellent customer service. With its in-depth knowledge of the European medical market, it was a natural choice to select Formulance as our distribution partner.

This partnership represents a significant step forward for both Biomerics and Formulance. By joining forces, we are committed to delivering cutting-edge solutions to medical device manufacturers across Europe.

For media inquiries, please contact :

Gabriel Perrier

Group Head of Communications
gabriel.perrier@formulance.com